IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
IAI.01370-07v1
76/6/2469    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shanks, R. M. Q.
Right arrow Articles by O'Toole, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shanks, R. M. Q.
Right arrow Articles by O'Toole, G. A.

 Previous Article  |  Next Article 

Infection and Immunity, June 2008, p. 2469-2477, Vol. 76, No. 6
0019-9567/08/$08.00+0     doi:10.1128/IAI.01370-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Genetic Evidence for an Alternative Citrate-Dependent Biofilm Formation Pathway in Staphylococcus aureus That Is Dependent on Fibronectin Binding Proteins and the GraRS Two-Component Regulatory System{triangledown}

Robert M. Q. Shanks ,1,{dagger},{ddagger} Michael A. Meehl,1,{dagger},§ Kimberly M. Brothers,1 Raquel M. Martinez,1 Niles P. Donegan,1 Martha L. Graber,2 Ambrose L. Cheung,1 and George A. O'Toole1*

Department of Microbiology and Immunology, Dartmouth Medical School, Hanover, New Hampshire 03755,1 Department of Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire 037662

Received 10 October 2007/ Returned for modification 11 November 2007/ Accepted 6 March 2008

We reported previously that low concentrations of sodium citrate strongly promote biofilm formation by Staphylococcus aureus laboratory strains and clinical isolates. Here, we show that citrate promotes biofilm formation via stimulating both cell-to-surface and cell-to-cell interactions. Citrate-stimulated biofilm formation is independent of the ica locus, and in fact, citrate represses polysaccharide adhesin production. We show that fibronectin binding proteins FnbA and FnbB and the global regulator SarA, which positively regulates fnbA and fnbB gene expression, are required for citrate's positive effects on biofilm formation, and citrate also stimulates fnbA and fnbB gene expression. Biofilm formation is also stimulated by several other tricarboxylic acid (TCA) cycle intermediates in an FnbA-dependent fashion. While aconitase contributes to biofilm formation in the absence of TCA cycle intermediates, it is not required for biofilm stimulation by these compounds. Furthermore, the GraRS two-component regulator and the GraRS-regulated efflux pump VraFG, identified for their roles in intermediate vancomycin resistance, are required for citrate-stimulated cell-to-cell interactions, but the GraRS regulatory system does not impact the expression of the fnbA and fnbB genes. Our data suggest that distinct genetic factors are required for the early steps in citrate-stimulated biofilm formation. Given the role of FnbA/FnbB and SarA in virulence in vivo and the lack of a role for ica-mediated biofilm formation in S. aureus catheter models of infection, we propose that the citrate-stimulated biofilm formation pathway may represent a clinically relevant pathway for the formation of these bacterial communities on medical implants.


* Corresponding author. Mailing address: Department of Microbiology and Immunology, Dartmouth Medical School, Room 505, Vail Building, N. College Street, Hanover, NH 03755. Phone: (603) 650-1248. Fax: (603) 650-1245. E-mail: georgeo{at}dartmouth.edu

{triangledown} Published ahead of print on 17 March 2008.

Editor: A. Camilli

{dagger} R.M.Q.S. and M.A.M. contributed equally to this report.

{ddagger} Present address: Department of Ophthalmology, UPMC Eye Center, University of Pittsburgh, Pittsburgh, PA 15213.

§ Present address: GlycoFi, Inc./Merck & Co. Inc., Lebanon, NH 03766.


Infection and Immunity, June 2008, p. 2469-2477, Vol. 76, No. 6
0019-9567/08/$08.00+0     doi:10.1128/IAI.01370-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2008 by the American Society for Microbiology. All rights reserved.